ALK and non-small cell lung carcinoma: Recently, synergistic effects between radiation and tyrosine kinase inhibitors (TKIs) targeting ALK rearrangement have been demonstrated 21-22 and, under certain circumstances, radiotherapy may improve survival in patients with advanced oncogene-driven NSCLC 23-24.